Psoriasis is a chronic inflammatory disease that affects approximately 7.5 million people in
the United States. The disease results in significant suffering, morbidity, and economic …

The burden of visible skin diseases (VSDs) includes not only physical symptoms but also
psychosocial consequences such as depression, anxiety, impaired quality of life and low …

Objective To compare quality of life (QoL), anxiety and depressive symptoms, alcohol
consumption and other correlates between patients with psoriasis and controls; and to …

Background Skin disease is a global public health problem that often has physiological,
psychological and social impacts. However, it is not very clear how to adapt to these …

The magnitude of the association between psoriasis and depression has been evaluated,
but not that between psoriasis and anxiety. The aim of this systematic review and meta …

Introduction: Psoriasis is a chronic inflammatory disease with a global prevalence of
approximately 2% and significant psychiatric comorbidity. There is a great deal of existing …

Background Psoriasis can lead to high psychosocial burden, and the occurrence of
psoriasis is related to psychological distress. Objectives This study provides an overview of …

In the mid-1990s, Thomas F. Cash developed the construct of appearance investment and
an instrument to measure it, the Appearance Schemas Inventory (ASI). This was followed by …

Depression is a major neuropsychiatric disorder common in patients with rheumatological
conditions including spondyloarthritis (SpA). It is associated with higher disease activity …

Previous studies have reported a higher incidence of depression and anxiety in psoriasis
patients compared to the general population, which has important implications for …